Collaborative research efforts have seen a novel monoclonal antibody, suvratoxumab, complete a Phase II trial targeted towards Staphylococcus aureus. This SAATELLITE study comes as the first clinical trial in the Innovative Medicines Initiative, formed to develop alternative medicines to combat antibiotic resistance.
Browsing: Disease Area > Bacterial
A shortened 15 second application time and a simpler three-step method for alcohol-based hand rub is as effective in reducing bacteria as the 30-second, six-step technique recommended by the WHO, according to research presented at ECCMID.
Staying in a hotel or private accommodation has been associated with carrying ESBL-producing bacteria in travelers to low- and middle-income countries, according to research presented at ECCMID.
New research presented at ECCMID has identified a novel association between antimicrobial resistance and climatic factors in Europe.
The ECDC has reported that the burden of healthcare-associated infections is substantial and variability in microbiological testing suggests these infections could be managed better, according to research presented at ECCMID.
Research presented at ECCMID has highlighted large variations in mortality rate associated with different bloodstream infections, as well as the threat posed by these infections.
Only one-third of patients entering the emergency department with a suspected UTIs actually have evidence of infection, however, almost all were treated with antibiotics, according to research presented at ECCMID.
Contamination of privacy curtains with multidrug-resistant organisms could be a common issue and a source of transmission to patients, according to research presented at ECCMID.
Pseudomonas aeruginosa uses a phage to trick the host’s immune system into ignoring it, in turn suppressing bacterial clearance from infected wounds, according to new research.